In contrast, our study revealed that the highest levels of PBX1 in tumor tissue are associated with poor response to induction chemotherapy, whereas PBX1 levels were decreased in non-responders (Figures 1M–O, 2M–O). This evidence concerns the gene PBX1 and neoplasm.